TMAO compound may play role in cardiovascular disease risk

04/26/2013 | WebMD

Individuals with the highest levels of trimethylamine-N-oxide, a compound produced in the stomach, were 2.5 times more likely to suffer a heart attack, stroke or heart disease than were those with the lowest TMAO levels, a study showed. The compound can make it more difficult for the liver and intestines to remove cholesterol, lead researcher Dr. Stanley Hazen said. The findings were published in The New England Journal of Medicine.

View Full Article in:

WebMD

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI